Researchers analyzed the efficacy of rifaximin for relieving IBS-D symptoms, specifically abdominal pain, bloating, and bowel movement urgency.
Drug therapy for the treatment of irritable bowel syndrome (IBS).
The approval was based on two phase 3 trials which evaluated Ibsrela in over 1200 adults with IBS-C.
Regulora is designed to provide seven 30-minute sessions of remote behavioral therapy based on gut-directed hypnotherapy.
The updated label now states that the treatment is contraindicated in patients less than 2 years of age due to the risk of serious dehydration.
GanedenBC30 (Bacillus coagulans GBI-30, 6086), lysine; vegetarian caps; lactose-free; may contain trace amounts of casein (milk protein).
Unlike phosphate binders, tenapanor decreases paracellular phosphate absorption in the intestine.